SEARCH

SEARCH BY CITATION

References

  • Abelson A. L., Shelton G. D., Whelan M. F., Cornejo L. & O’Toole T. E. (2009) Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs. Journal of Veterinary Emergency and Critical Care 19, 369374
  • Affolter V. K. & Moore P. F. (2000) Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. American Journal of Dermatopathology 22, 4048
  • Al-Ghazlat S. (2009) Immunosuppressive therapy for canine immune-mediated hemolytic anemia. Compendium on Continuing Education for the Practicing Veterinarian 31, 3341
  • Allenspach K., Wieland B., Grone A. & Gascehn F. (2007) Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. Journal of Veterinary Internal Medicine 21, 700708
  • Allenspach K., Rufenacht S., Sauter S., Grone A., Steffan J., Strehlau G. & Gaschen F. (2006a) Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease. Journal of Veterinary Internal Medicine 20, 239244
  • Allenspach K., Bergman P. J., Sauter S., Grone A., Doherr M. G. & Gaschen F. (2006b) P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. Journal of Comparative Pathology 134, 17
  • Allyn M. E. & Troy G. C. (2007) Immune-mediated haemolytic anaemia - a retrospective study - focus on treatment and mortality (1988-1996) (abstract). Journal of Veterinary Internal Medicine 11, 131
  • Anthony R. M., Nimmerjahn F., Ashline D. J.Reinhold V. N., Paulson J. C. & Ravetch J. V. (2008) Recapitulation of IVIG anti-inflammatory activity with recombinant IgG Fc. Science 320, 373376
  • Appel G. B., Radhakrishnan J. & Ginzler E. (2005) Use of mycophenolate mofetil in autoimmune and renal diseases. Transplantation 80, S272S274
  • Ashwell J. D., Lu F. W. & Vacchio M. S. (2000) Glucocorticoids in T cell development and function. Annual Review of Immunology 18, 309345
  • Baptist A. P. & Reddy R. C. (2009) Inhaled corticosteroids for asthma: are they all the same? Journal of Clinical Pharmacology and Therapeutics 34, 112
  • Barker R. N., Gruffydd-Jones T. J., Stokes C. R. & Elson C. J. (1991) Identification of autoantigens in canine autoimmune haemolytic anaemia. Clinical and Experimental Immunology 85, 3340
  • Battersby I., Whitley N., Littler R. M. & Elwood C. (2007) Budesonide therapy in dogs with inflammatory gastrointestinal disease. Proceedings of British Small Animal Veterinary Association. April 12 to 15, Birmingham UK. p 476
  • Bayry J., Kazatchkine M. D. & Kavari S. V. (2007) Shortage of human immunoglobulin - reasons and possible solutions. Nature Clinical Practice in Neurology 3, 120121
  • Beale K. M. (1988) Azathioprine for treatment of immune-mediated diseases of dogs and cats. Journal of the American Veterinary Medical Association 192, 13161318
  • Bettelli E., Korn T. & Kuchroo V. K. (2007) Th17: the third member of the effector T cell trilogy. Current Opinion in Immunology 19, 652657
  • Bexfield N. H., Watson P. J. & Herrtage M. E. (2006) Management of myasthenia gravis using cyclosporine in 2 dogs. Journal of Veterinary Internal Medicine 20, 14871490
  • Bianco D., Armstrong P. J. & Washabau R. J. (2009) A prospective randominsed, double-blinded, placebo controlled study of human intravenous immunoglobulin for the acute management of presumptive immune mediated thrombocytopenia in dogs. Journal of Veterinary Internal Medicine 23, 10711078
  • Bianco D., Armstrong P. J. & Washabau R. J. (2007) Treatment of severe immune mediated thrombocytopenia with human IV immunoglobulin in 5 dogs. Journal of Veterinary Internal Medicine 21, 694699
  • Bianco D. & Hardy R. M. (2009) Treatment of Evans’ syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog. Journal of the American Animal Hospital Association 45, 147150
  • Biller B. J., Elmslie R. E., Burnett R. C., Avery A. C. & Dow S. W. (2007) Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Veterinary Immunology and Immunopathology 116, 6978
  • Blackwood L., German A. J., Stell A. J. O’Neill T. (2004) Multicentric lymphoma in a dog after ciclosporine therapy. Journal of Small Animal Practice 45, 259262
  • Bloom J. C., Meunier L. D., Thiem P. A. & Sellers T. S. (1989) Use of danazol for treatment of corticosteroid resistant immune-mediated thrombocytopenia in a dog. Journal of the American Veterinary Medical Association 194, 7678
  • Bommer N. X., Shaw D. J., Milne E. M. & Ridyard A. E. (2008) Platelet distribution width and mean platelet volume in the interpretation of thrombocytopenia in dogs. Journal of small animal practice 49, 518524
  • Brattsand R. (1990) Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Canadian Journal of Gastroenterology 4, 407414
  • Burgess K., Moore A., Rand W. & Cotter S. M. (2000) Treatment of immune mediated hemolytic anemia in dogs with cyclophosphamide. Journal of Veterinary Internal Medicine 14, 456462
  • Buttgereit F. & Scheffold A. (2002) Rapid glucocorticoid effects on immune cells. Steroids 67, 529534
  • Callan M. B., Preziosi D. & Mauldin E. (2005) Multiple papillomavirus associated epidermal hamartomas and squamous cell carcinoma in situ in a dog following chronic treatment with prednisolone and ciclosporine. Veterinary Dermatology 16, 338345
  • Carr A. P., Panciera D. L. & Kidd L. (2002) Prognostic factors for mortality and thromboembolism in canine immune mediated haemolytic anaemia: a retrospective study of 72 Dogs. Journal of Veterinary Internal Medicine 16, 504509
  • Center S. A., Smith C. A., Wilkinson E., Erb H. N. & Lewis R. M. (1987) Clinicopathologic, renal immunofluorescent, and light microscopic features of GN in the dog: 41 cases (1975-1985). Journal of the American Veterinary Medical Association 190, 8190
  • Chastain C. B. & Panciera D. (2002) Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Small Animal Clinical Endocrinology 12, 11
  • Christian J. A., Rebar A. H., Boon G. D. & Low P. S. (1993) Senescence of canine biotinylated erythrocytes: increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days. Blood 82, 34693473
  • Cohn L. A., DeClue A. E. & Reinero C. R. (2008) Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs. Journal of Veterinary Internal Medicine 22, 3743
  • Colopy S. A., Baker T. A. & Muir P. (2010) Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). Journal of the American Veterinary Medical Association 236, 312318
  • Cook A. K., Bertoy E. H., Gregory C. R. & Stewart A. F. (1994) Effect of oral cyclosporine in dogs with refractory immune-mediated anaemia or thrombocytopenia (abstract). Journal of Veterinary Internal Medicine 8, 170
  • Cook A. K. & Cowgill L. D. (1996) Clinical and pathological features of protein losing glomerular disease in the dog: a review of 137 cases (1985-1992). Journal of the American Animal Hospital Association 32, 313322
  • Craven M., Simpson J. W., Ridyard A. E. & Chandler M. L. (2004) Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). Journal of Small Animal Practice 45, 336342
  • Creed T. J., Norman M. R., Probert C. S., Harvey R. F., Shaw I. S., Smithson J., Anderson J., Moorghen M., Gupta J., Shepherd N. A., Dayan C. M. & Hearing S. D. (2003) Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. Alimentary Pharmacology and Therapeutics 18, 6575
  • Creed T. J., Probert C. S., Norman M. N., Moorghen M., Shepherd N. A., Hearing S. D. & Dayan C. M. (2006) Basiliximab for the treatment of -steroid-resistant ulcerative colitis: further experience in moderate and severe -disease. Alimentary Pharmacology and Therapeutics 23, 14351442
  • Creed T. J., Lee R. W., Newcomb P. V., di Mambro A. J., Raju M. & Dayan C. M. (2009) The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone. Journal of Immunology 183, 164171
  • Danovitch G. (2005) Mycophenolate mofetil: a decade of clinical experience. Transplantation 80, S272S273
  • Day M. J. (1999) Antigen specificity in canine autoimmune haemolytic anaemia. Veterinary Immunology and Immunopathology 69, 215224
  • Day M. J. (2005) Immunotherapy. In: Advances in Veterinary Dermatology. Volume 5. Eds A.Hillier A. P.Foster and K. W.Kwochka. Blackwell Publishing Ltd., Oxford. pp 107122
  • Day M. J. (2008a) Corticosteroids and antihistamines. In: Small Animal Clinical Pharmacology. 2nd edn. Eds J. E.Maddison S. W.Page and D. B.Church. Saunders Elsevier, Philadelphia PA. pp 261269
  • Day M. J. (2008b) Immunomodulatory therapy. In: Small Animal Clinical Pharmacology. 2nd edn. Eds J. E.Maddison S. W.Page and D. B.Church. Saunders Elsevier, Philadelphia PA. pp 270286
  • Day M. J. & Mackin A. J. (2008) Immune-mediated haematological disease. In: Clinical Immunology of the Dog and Cat. 2nd edn. Ed M. J.Day. Manson Publishing, London UK. pp 94121
  • Day M. J., Bilzer T., Mansell J., Wilcock B., Hall E. J., Jergens A., Minami T., Willard M. & Washabau R. J. (1998) Histopathological standards for diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardisation Group. Journal of Comparative Pathology 138(Suppl 1), S1S43
  • Dewey C. W., Boothe D. M. & Wilkie W. S. (2001) Pharmacokinetics of single-dose oral and intravenous mycophenolate mofetil administration in normal dogs (abstract). Journal of Veterinary InternalMedicine 15, 304
  • Dewey C. W., Coates J. R., Ducote J. M., Meeks J. C. & Fradkin J. M. (1999) Azathioprine therapy for acquired myasthenia gravis in five dogs. Journal of the American Animal Hospital Association 35, 396402
  • Dewey C. W., Bailey C. S., Shelton G. D., Kass P. H. & Cardinet G. H. (1997) Clinical forms of acquired myaesthenia gravis in dogs: 25 cases (1988-1995). Journal of Veterinary Internal Medicine 11, 5057
  • Dewey C. W., Boothe D. M., Rinn K. L., Coates J. R. & Burkholder W. J. (2000) Treatment of a myasthenic dog with mycophenylate mofetil. The Journal of Veterinary Emergency and Critical Care 10, 177187
  • Dewey C. W., Harb-Houser M. F., Cerda-Gonzalez S., Levine J. M., Bagley B. L., Olby N. J., Kent M., Birnbaum N. & Shelton G. D. (2008) Mycophenylate mofetil therapy for acquired myaesthenia gravis in dogs: a comparative retrospective study (1999-2007) (abstract). Journal of Veterinary Internal Medicine 22, 721
  • Dewey C. W., Cerda-Gonzalez S., Fletcher D. J., Harb-Hauser M. F., Levine J. M., Badgley B. L., Olby N. J. & Shelton G. D. (2010) Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008). Journal of the American Veterinary Medical Association 236, 664668
  • Dewey C. W., Shelton D., Bailey C. S., Willard M. D., Podell M. & Colllins R. L. (1995) Neuromuscular dysfuction in five dogs with acquired myasthenia gravis and presumptive hypothyroidism. Progress in Veterinary Neurology 6, 117123
  • Dircks B. H., Schuberth H. J. & Mischke R. (2009) Underlying diseases and clinicopathological variables of thrombocytopenic dogs with and without platelet bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006). Journal of the American Veterinary Medical Association 235, 960966
  • Elwood C. & Polton G. (2008) Correspondence. Journal of Veterinary Internal Medicine 22, 1075
  • Ercolini A. M. & Miller S. D. (2009) The role of infections in autoimmune disease. Clinical and Experimental Immunology 155, 115
  • Erem C., Nuhoglu I., Yilmaz M., Kocak M., Demirel A., Ucuncu O. & Onder Ersoz H. (2009) Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin- activatable fibrinolysis inhibitor levels. Journal of Endocrinological Investigation 32, 169174
  • Fenty R. K., de Laforcade A. M., Shaw S. P. & O’Toole T. E. (2008) Identification of hypercoagulability in dogs with primary immune-mediated haemolytic anaemia utilizing thromboelastography (abstract). Journal of Veterinary Emergency and Critical Care 18, 411
  • Foster A. P., Knowles T. G., Hotston-Moore A., Cousins P. G. D., Day M. J. & Hall E. J. (2003) Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease. Veterinary Immunology and Immunopathology 92, 113124
  • Galin F. S., Chrisman C. L., Cook J. R., Jr, Xu L., Jackson P. L., Noerager B. D., Weathington N. M. & Blalock J. E. (2007) Possible therapeutic vaccines for canine myasthenia gravis: implications for the human disease and associated fatigue. Brain, Behaviour and Immunity 21, 323331
  • Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., O’Shea J. J., Chrousos G. P. & Bornstein S. R. (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 1, 6171
  • Garcia-Sancho M., Rodriguez-Franco F., Sainz A., Mancho C. & Rodriguez A. (2007) Evaluation of clinical, macroscopic and histopathologic response to treatment in nonhypoproteinemic dogs with lymphocytic-plasmacytic enteritis. Journal of Veterinary Internal Medicine 21, 1117
  • Grau-Bassas E. R., Kociba G. J. & Couto G. C. (2000) Vincristine impairs platelet aggregation in dogs with lymphoma. Journal of Veterinary Internal Medicine 14, 8185
  • Grauer G. S., Greco D. S., Getzy D. M., Cowgill L. D., Vaden S. L., Chew D. J., Polzin D. J. & Barsanti J. A. (2000) Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. Journal of Veterinary Internal Medicine 14, 526
  • Grauer G. F. (2005) Canine glomerulonephritis: new thoughts on proteinuria and treatment. Journal of Small Animal Practice 46, 469478
  • Greene C. E., Scoggin J., Thomas J. E. & Barsanti J. A. (1982) Vincristine in the treatment of thrombocytopenia in five dogs. Journal of the American Veterinary Medical Association 180, 140143
  • Gregory C. R., Silva H. T., Patz J. D. & Morris R. E. (1998a) Comparative effects of malanonitrotolamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs and rats. Transplantation Proceedings 30, 10471048
  • Gregory C. R., Stewart A., Sturges T., DeManvelle T., Cannon A., Ortega M., Harb M. & Morris R. E. (1998b) Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy. Transplantation Proceedings 30, 41434148
  • Griffiths L. G., Sullivan M. & Borland W. W. (1999) Cyclosporin as the sole treatment for anal furunculosis: preliminary results. Journal of small animal practice 40, 569572
  • Grundy S. A. & Barton C. (2001) Influence of drug treatment on survival of dogs with immune-mediated haemolytic anaemia: 88 cases (1989-1999). Journal of the American Veterinary Medical Association 218, 543546
  • Guilford W. G., Jones W. G., Markwell P. J., Arthur D. G., Collett M. G. & Harte J. G. (2001) Food sensitivity in cats with chronic idiopathic gastrointestinal problems. Journal of Veterinary Internal Medicine 15, 713
  • Hardie R. J., Gregory S. P., Tomlin J., Sturgeon C., Lipscomb V. & Ladlow J. (2005) Cyclosporine treatment of anal furunculosis in 26 dogs. Journal of Small Animal Practice 46, 39
  • Hearing S. D., Norman M., Probert C. S., Haslam N. & Dayan C. M. (1999) Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45, 382388
  • Horiuchi Y., Nakajima Y., Nariai Y., Asanuma H., Kuwabara M. & Yukawa M. (2007) Th1/Th2 balance in canine peripheral blood lymphocytes - a flow cytometric study. Veterinary Immunology and Immunopathology 118, 179185
  • Houston D. M. & Taylor J. A. (1991) Acute pancreatitis and bone marrow suppression in a dog given azathioprine. Canadian Veterinary Journal 32, 496497
  • Husbands B., Polzin D., Armstrong P. J., Cohn L. & Patterson N. E. (2004) Prednisone and cyclosporine vs prednisone alone for treatment of canine immune mediated hemolytic anemia. Journal of Veterinary Internal Medicine 18, 389
  • Jackson M. L. & Kruth S. A. (1985) Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Canadian Veterinary Journal 26, 245250
  • Jacob F., Polzin D. J., Osborne C. A., Neaton D. J., Kirk C. A., Allen C. A. & Swanson L. L. (2005) Evaluation of the association between initial proteinuria and morbidity or death in dogs with naturally occurring chronic renal failure. Journal of the American Veterinary Medical Association 226, 393
  • Jans H. E., Armstrong J. & Price G. S. (1990) Therapy of immune mediated thrombocytopenia. Journal of Veterinary Internal Medicine 4, 47
  • Jergens A. E., Schreiner C. A., Dagmar E. F., Niyo Y., Ahrens F. E., Eckersall P. D., Benson T. J. & Evans R. (2003) A scoring index for disease activity in canine inflammatory bowel disease. Journal of Veterinary Internal Medicine 17, 291297
  • Jergens A. E., Crandell J., Morrison J. A., Deitz K., Pressel M., Ackermann M., Suchodolski J. S., Steiner J. M. & Evans R. (2010) Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. Journal of Veterinary Internal Medicine 24, 269277
  • Juel V. C. & Massey J. M. (2005) Autoimmune myasthenia gravis: recommendations for treatment and immunologic modulation. Current Treatment Options in Neurology 7, 314
  • Kaneko Y., Nimmerjahn F. & Ravectch J. V. (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670673
  • Kellerman D. L. & Bruyette D. S. (1997) Intravenous human immunoglobulin for the treatment of immune mediated haemolytic anaemia in 13 dogs. Journal of Veterinary Internal Medicine 11, 327332
  • Kennedy L. J., Barnes A., Ollier W. E. R. & Day M. J. (2006a) Association of a common DLA class II haplotype with canine primary immune-mediated haemolytic anaemia. Tissue Antigens 68, 502506
  • Kennedy L. J., Quarmby S., Happ G. M., Barnes A., Ramsey I. K., Dixon R. M., Catchpole B., Rusbridge C., Graham P. A., Hillbertz N. S., Roethel C., Dodds W. J., Carmichael N. G. & Ollier W. E. (2006b) Association of canine hypothyroidism with a common major histocompatibility complex DLA class II allele. Tissue Antigens 68, 8286
  • Kidd L. B., Salavaggione O. E., Szumlanski C. L., Miller J. L., Weinshilboum R. M. & Trepanier L. (2004) Thiopurine methyltransferase activity in red blood cells of dogs. Journal of Veterinary Internal Medicine 18, 214218
  • Klein M. K., Dow S. W. & Rosychuk R. A. W. (1989) Pulmonary thromboembolism associated with immune-mediated haemolytic anaemia in dogs: ten cases (1982-1987). Journal of the American Veterinary Medical Association 195, 246250
  • Klag A. R., Giger U. & Shofer F. S. (1993) Idiopathic immune mediated haemolytic anaemia in dogs: 42 cases (1986-1990). Journal of the American Veterinary Medical Association 202, 783788
  • Korn T., Magnus T., Toyka K. & Jung S. (2004) Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide - mechanisms independent of pyrimidine depletion. Journal of Leukocyte Biology 76, 950960
  • Kyewski B. & Taubert R. (2008) How promiscuity promotes tolerance: the case of myasthenia gravis. Annals of the New York Academy of Science 1132, 157162
  • Kyles A. E., Gregory C. R., Griffey S. M., Bernsteen L., Jackson J. & Morris R. E. (2001) Leflunomide analog, MNA-715, plus cyclosporine reduces renal allograft rejection in mismatched dogs. Transplantation Proceedings 33, 368369
  • Kyles A. E., Gregory C. R., Griffey S. M., Bernsteen L., Pierce J., Lilja H. S. & Morris R. E. (2003) Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs. Transplantation 75, 11281133
  • Langman L. J., Shapiro A. M., Lakey J. R., LeGatt D. F., Kneteman N. M. & Yatscoff R. W. (1996) Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model. Transplantation 61, 8792
  • Larche M. & Wraith D. C. (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nature Medicine 11, S69S76
  • Lewis D. C. & Meyers K. M. (1996) Canine idiopathic thrombocytopenia purpura. Journal of Veterinary Internal Medicine 10, 207218
  • Lindstrom J. M., Shelton D. & Fujii Y. (1988) Myasthenia gravis. Advances in Immunology 42, 233284
  • Lirtzman R. A., Gregory C. R., Levitski R. E., Griffey S. M., Yeh L. S., Patz J. D. & Morris R. E. (1996) Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model. Transplantation Proceedings 28, 945947
  • Lunn K. F. (2009) Innovative therapies for immune-mediated hemolysis in dogs. Proceedings of the American College of Veterinary Internal Medicine forum June 3-6, Montreal, Canada. pp 549-551
  • Mackin A. J., Allen D. G. & Johnstone I. B. (1995) Effects of vincristine and prednisone on platelet numbers and function in clinically normal dogs. American Journal of Veterinary Research 56, 100108
  • MacMillan H. F., Lee T. & Issekutz A. C. (2009) Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects and endogenous mechanism by which IgG modulates T-cell activation. Clinical Immunology 132, 222233
  • Maddison J. E., Waelchli-Suter C. M. & Johnson R. P. (1984) Clinical remission after corticosteroid therapy of acquired myasthenia gravis in three dogs. Journal of the American Veterinary Medical Association 184, 845848
  • Mason N., Duval D., Shofer F. & Giger U. (2003) Cyclophosphamide exerts no beneficial effect over prednisolone alone in the treatment of acute immune-medated haemolytic anaemia in dogs: a randomised controlled clinical trial. Journal of Veterinary Internal Medicine 17, 206212
  • Mathes M., Jordan M. & Dow S. (2006) Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs. Experimental Hematology 34, 13931402
  • Mathews K. A. & Sukhiani H. R. (1997) Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs. Journal of the American Veterinary Medical Association 211, 12491253
  • McChesney L. P., Xiao F., Sankary H. N., Foster P. F., Sharma S., Haklin M. & Williams J. W. (1994) An evaluation of leflunomide in the canine renal transplantation model. Transplantation 57, 17171722
  • McManus P. & Craig L. (2001) Correlation between leucocytosis and necropsy findings in dogs with immune mediated haemolytic anaemia. Journal of the American Veterinary Medical Association 218, 13081313
  • Medzhitov R. (2009) Approaching the asymptote: 20 years later. Immunity 30, 766775
  • Mehling A., Grabbe S., Voskort M., Schwarz T., Luger T. A. & Beissert S. (2000) Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. Journal of Immunology 165, 23742381
  • Mellanby R. J., Mee A. P., Berry J. L. & Herrtage M. E. (2005) Hypercalcaemia in two dogs caused by excessive dietary supplementation of vitamin D. Journal of Small Animal Practice 46, 334338
  • Miller E. (1992) Immunosuppressive therapy in the treatment of immune mediated disease. Journal of Veterinary Internal Medicine 6, 206213
  • Miller E. (1997) Danazol therapy for the treatment of immune mediated haemolytic anaemia in dogs (abstract). Journal of Veterinary Internal Medicine 11, 130
  • Miller M. D. & Lunn K. F. (2007) Diagnostic use of cytologic examination of bone marrow from dogs with thrombocytopenia: 58 cases (1994-2004). Journal of the American Veterinary Medical Association 231, 15401544
  • Misseghers B. S., Binnington A. G. & Mathews K. A. (2000) Clinical observations of the treatment of canine perianal fistulas in the dog. Australian Veterinary Journal 80, 207211
  • Mitchell K. D., Kruth S. A., Wood R. D. & Jefferson B. (2009) Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. Journal of Veterinary Internal Medicine 23, 585591
  • Miyauchi Y., Nakayama H., Uchida K., Uetsuka K., Hasegawa A. & Goto N. (1992) Glomerulopathy with IgA deposition in the dog. Journal of Veterinary Medical Science 54, 969975
  • Mossman T. R., Cherwinski H., Bond M. W., Giedlin M. A. & Coffman R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136, 2348
  • Mouatt J. G. (2002) Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog. Australian Veterinary Journal 80, 207211
  • Nichols R. (1994) Concurrent illness and complications associated with canine hyperadrenocorticism. Seminars in Veterinary Medicine and Surgery (Small Animal) 9, 132136
  • Nielsen L., Niessen S., Ramsay M. & Ramsay I. K. (2005) The use of mycophenolate mofetil in eight dogs with idiopathic immune mediated haemolytic anaemia. Proceeding of 15th ECVIM-CA Congress, September 1-3, Glasgow, Scotland. p 219
  • Nuttall T. J. & Malham T. (2004) Successful intravenous human immunoglobulin treatment of drug-induced Stevens-Johnson syndrome in a dog. Journal of Small Animal Practice 45, 357361
  • O’Garra A. & Vieira P. (2004) Regulatory T cells and mechanisms of immune system control. Nature Medicine 10, 801805
  • Ogilvie G. K., Felsburg P, J. & Harris C. W. (1988) Short-term effect of cyclophosphamide and azathioprine on selected aspects of the canine blastogenic response. Veterinary Immunology and Immunopathology 18, 119127
  • Olivry T. & Mueller R. S. (2003) Evidence based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 14, 121146
  • Olivry T., Foster A. P., Mueller R. S., McEwan N. A., Chesney C. & Williams H. C. (2010) Interventions for atopic dermatitis in dogs: a systemic review of randomised controlled trials. Veterinary Dermatology 21, 422
  • Patrassi G. M., Sartori M. T., Livi U., Casonato A., Danesin C., Vettore S. & Girolami A. (1997) Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation. Transplantation 64, 16101614
  • Patricelli A. J., Hardie R. J. & McAnulty J. F. (2002) Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. Journal of the American Veterinary Medical Association 220, 10091016
  • Piek C. J., Junius G., Dekker E., Schrauwen E., Slappendal R. J. & Teske E. (2008) Idiopathic immune-mediated haemolytic anaemia: treatment, outcome and prognostic factors in 149 dogs. Journal of Veterinary Internal Medicine 22, 366373
  • Platz K. P., Sollinger H. W., Hullett D. A., Eckhoff D. E., Eugui E. M. & Allison A. C. (1991) RS-61443 - a new potential immunosuppressive agent. Transplantation 51, 2731
  • Rahilly L. J., Keating J. H. & O’Toole T. E. (2006) The use of intravenous human immunoglobulin in treatment of severe pemphigus foliaceus in a dog. Journal of Veterinary Internal Medicine 20, 14831486
  • Reagan W. J., Scott-Moncrieff C., Christian J., Snyder P., Kelly K. & Glickman L. (1998) Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes. American Journal of Veterinary Research 59, 15681574
  • Reimer M. E., Troy G. C. & Warnick L. D. (1999) Immune-mediated haemolytic anaemia: 70 cases (1988-1996). Journal of the American Animal Hospital Association 35, 384391
  • Rinkardt N. E. & Kruth S. A. (1996) Azathioprine-induced bone marrow toxicity in four dogs. Canadian Veterinary Journal 37, 612613
  • Rinkardt N. E., Kruth S. A. & Kaushik A. (1999) The effects of prednisone and azathioprine on circulating immunoglobulin levels and lymphocyte subpopulations in normal dogs. Canadian Journal of Veterinary Research 63, 1824
  • Robson D. (2003) Review of the pharmacokinetics, interactions and adverse reaction of ciclosporine in people, dogs and cats. Veterinary Record 152, 739748
  • Rose L., Bedard C. & Dunn M. (2008) Effect of prednisone administration of thromboelastography parameters in healthy beagles (abstract). Journal of Veterinary Internal Medicine 22, 738739
  • Rose L., Dunn M. & Bedard C. (2009) Effect of canine hyperadrenocorticism of thromboelastography parameters (abstract). Journal of Veterinary Internal Medicine 23, 692
  • Roseler B. J. & Mason K. V. (1994) Use of danazol and corticosteroids for the treatment of immune-mediated thrombocytopenia in a dog. Australian Veterinary Practice 24, 126130
  • Rozanski E. A., Callan M. B., Hughes D., Sanders N. & Giger U. (2002) Comparison of platelet count recovery with the use of vincristiine and prednisolone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs. Journal of the American Veterinary Medical Association 220, 477481
  • Salavaggione O. E., Kidd L., Prondzinski J. L., Szumlanski C. L., Pankratz V. S., Wang L., Trepanier L. & Weinshilboum R. M. (2002) Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics. Pharmacogenetics 12, 713724
  • Saridomichelakis M. N. (2009) Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications. Veterinary Dermatology 20, 471489
  • Sartori M. T., Patrassi G. M., Rigotti P., Marchini F., Fioretti M., Spiezia L. & Girolami A. (2000) Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 69, 21162121
  • Scott-Moncrieff J. C., Treadwell N. G., McCullough S. M. & Brooks M. B. (2001) Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia. Journal of the American Animal Hospital Association 37, 220227
  • Schreiner N. M. S., Gaschen F., Grone A., Sauter S. N. & Allenspach K. (2008) Clinical signs, histology and CD-3 positive cells before and after treatment of dogs with chronic enteropathies. Journal of Veterinary Internal Medicine 22, 10791083
  • Shelton D. (1998a) Myasthenia gravis: laboratory diagnosis and predictive factors. Proceedings of 16th Annual Veterinary Medical Forum ACVIM, May 22-25, San Diego USA. pp 309310
  • Shelton D. (1998b) Myasthenia gravis: lessons from the past 10 years. Journal of Small Animal Practice 39, 368372
  • Shelton G. D. & Lindstrom J. M. (2001) Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies. Neurology 57, 21392141
  • Shelton G. D. (2002) Myasthenia gravis and disorders of neuromuscular transmission. Veterinary Clinics of North America: Small Animal Practice 32, 189206
  • Sinnott V. B. & Otto C. M. (2009) Use of thromboelastography in dogs with immune-mediated haemolytic anaemia: 39 cases (2000-2008). Journal of Veterinary Emergency and Critical Care 19, 484488
  • Smith C. S. & Pell J. P. (2003) Parachute use to prevent death and major trauma related to gravitational challenge: a systematic review of randomised controlled trials. British Medical Journal 327, 14591461
  • Smith S. A. (2007) Hemostatic complications of canine IMHA. Proceedings of the 25th ACVIM Forum, Seattle, WA
  • Soroosh P. & Taylor A. (2009) Th9 and allergic disease. Immunology 127, 450458
  • Stanley B. J. & Hauptman J. G. (2009) Long term prospective evaluation of topically applied 0.1% tacrolimus ointment for treatment of perianal sinuses in dogs. Journal of the American Veterinary Medical Association 235, 397404
  • Steffan J., Favrot C. & Mueller R. (2006) A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 17, 316
  • Stone M. S., Johnstone I. B., Brooks M., Bollinger T. K. & Cotter S. M. (1994) Lupus-type “anticoagulant” in a dog with haemolysis and thrombosis. Journal of Veterinary Internal Medicine 8, 5761
  • Strobel P., Chuang W. Y., Chuvpilo S., Zettl A., Katzenberger T., Kalbacher H., Rieckmann P., Nix W., Schalke B., Gold R., Muller-Hermelink H. K., Peterson P. & Marx A. (2008) Common cellular and diverse genetic basis of thymoma-associated myaesthenia gravis. Annals of the New York Academy of Science 1132, 143156
  • Su Y. C., Rolph M. S., Cooley M. A. & Sewell W. A. (2006) Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease. Journal of Allergy and Clinical Immunology 117, 635641
  • Tecles F., Spiranelli E., Bonfanti U., Ceron J. J. & Paltrineieri S. (2005) Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. Journal of Veterinary Internal Medicine 19, 865870
  • Tha-In T., Bayry J., Metselaar H. J., Kaveri S. V. & Kwekkeboom J. (2008) Modulation of the cellular immune system by intravenous immunoglobulin. Trends in Immunology 29, 608615
  • Thomason J. M., Lunsford A., Mackin A., Pinchuk L., Pruett S. & Langston C. (2009) Effects of cyclosporine on canine platelet procoagulant activity (abstract). Journal of Veterinary Internal Medicine 23, 692
  • Thomson M. F., Scott-Moncrieff J. C. & Brooks M. B. (2004) Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune mediated hemolytic anaemia. Journal of the American Animal Hospital Association 40, 446454
  • Trotman T. K., Phillips H., Fordyce H., King L. G., Morris D. O. & Giger U. (2006) Treatment of severe adverse cutaneous drug reactions with human intravenous immunoglobulin in two dogs. Journal of the American Animal Hospital Association 42, 312320
  • Tsuchiya R., Akutsu Y., Ikegami A., Scott M. A., Neo S., Ishikawa T., Hisasue M. & Yamada T. (2009) Prothrombotic and inflammatory effects of intravenous administration of human immunoglobulin G in dogs. Journal of Veterinary Internal Medicine 23, 11641169
  • Tumulty J. W., Broussard J. D., Steiner J. M., Peterson M. E. & Williams D. A. (2004) Clinical effects of short-term oral budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease. Journal of the American Animal Hospital Association 40, 120123
  • Ulutas B., Voyvoda H., Pasa S. & Alingan M. K. (2006) Clodronate treatment of vitamin D-induced hypercalcemia in dogs. Journal of Veterinary Emergency and Critical Care 16, 141145
  • Vaden S. L., Breitschwerdt E. B., Armstrong J., Correa M. T., Brown C., Polzin, D. J., Brace J. J., DiBartola S. P., Barsanti J. A., Crowell W., Jans H., Dimski D. S. & Bartges J. (1995) The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis. Journal of Veterinary Internal Medicine 9, 259266
  • Van Heerden J. & Van Schouwenburg S. J. (1983) The use of corticosteroids in a dog with myasthenia gravis. Journal of the South African Veterinary Association 54, 135137
  • Viard I., Wehru P., Bullani R., Schneider P., Holler N., Salomon D., Hunzikner T., Saurat J. H., Tschopp J. & French L. E. (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490493
  • Warman S. M., Murray J. K., Ridyard A., Eastwood J., Silva S. & Day M. J. (2008) Pattern of Coombs test reactivity has diagnostic significance in dogs with immune mediated haemolytic anaemia. Journal of Small Animal Practice 49, 525530
  • Washabau R. J., Day M. J., Willard M. D., Hall E. J., Jergens A. E., Mansell J., Minami T. & Bilzer T. W. (2010) Endoscopic, biopsy and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. Journal of Veterinary Internal Medicine 24, 1026
  • Weigmann B., Jarman E. R., Sudowe S., Bros M., Knop J. & Reske-Kunz A. B. (2006) Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity. Journal of Investigative Dermatology 126, 15241533
  • Weinkle T. K., Center S. A., Randolph J. F., Warner K. L., Barr S. C. & Erb H. N. (2005) Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated haemolytic anaemia in dogs: 151 cases (1993-2002). Journal of the American Veterinary Medical Association 226, 18691880
  • Weiss D. J. & Brazell J. L. (2006) Detection of activated platelets in dogs with primary immune-mediated haemolytic anaemia. Journal of Veterinary Internal Medicine 20, 682686
  • Wells R., Guth A., Lappin M. & Dow S. (2009) Anti-endothelial antibodies in dogs with immune-mediated haemolytic anaemia and other diseaseas associated with a high risk of pulmonary thromboembolism. Journal of Veterinary Internal Medicine 23, 295300
  • Whelan M. F., O’Toole T. E., Chan D. L., Rozanski E. A., de Laforcade A. M., Crawford S. L. & Cotter S. M. (2009) Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated haemolytic anaemia. Journal of Veterinary Emergency and Critical Care 19, 158164
  • Wilbe M., Jokinen P., Truve K., Seppala E. H., Karlsson E. K., Biagi B., Hughes A., Bannasch D., Andersson G., Hansson-Hamlin H., Lohi H. & Lindblad-Toh K. (2010) Genome-wide association mapping identified multiple loci for a canine SLE-related disease complex. Nature Genetics 42, 250255
  • Wilkerson M. J., Shuman W., Swist S., Harkin K., Meinkoth J. & Konan A. A. (2001) Platelet size, platelet-surface associated IgG, and reticulated platelets in dogs with immune-mediated thrombocytopenia. Veterinary Clinical Pathology 30, 141149
  • Williams D. A. & Maggio-Price L. (1984) Canine idiopathic thrombocytopenia: clinical observations and long-term follow up in 54 cases. Journal of the American Veterinary Medical Association 185, 660663
  • Wohl J. S. & Moore A. S. (1996) Use of single agent cyclosporine A in dogs with severe immune mediated haemolytic anaemia (abstract). Journal of Veterinary Internal Medicine 10, 173
  • Yasukawa K., Saito S., Kubo T.Shibasaki Y., Yamaoka K., Hachimura H., Kuyama T., Amimoto A, Kumata T., Kitahara Y., Takenaka M., Matsumura H., Uno T., Uchino T., Takehara K., Nishida K., Kadoya M., Sato M., Kato K., Matsumoto K., Saito S. & Shimoda T. (2010) Low-dose recombinant canine interferon-γ for treatment of canine atopic dermatitis: an open randomized comparative trial of two doses. Veterinary Dermatology 21, 4249
  • Yin H., He X., Bao X., Liu X. & Yang G. (2005) Impedance effects of interleukin-6 on cyclophosphamide-induced hematopoietic damnification in dogs (in Chinese). Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 22, 798801
  • Yuki M., Sugimoto N., Otsuka H., Tanahashi S., Katoh M.Hirano T., Nishii N. & Suzuki K. Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetil. Australian Veterinary Journal 85, 495497